Potential Biomarkers for Mild Cognitive Impairment in the Elderly
Author Information
Author(s): Meng Yuchi, Cheng Murong, Qu Hongyan, Song Zhenxue, Zhang Ling, Zeng Yuanjun, Zhang Dongfeng, Li Suyun
Primary Institution: Department of Epidemiology and Health Statistics, School of Public Health, Qingdao University, Qingdao, Shandong, China
Hypothesis
Can targeted plasma metabolomics identify biomarkers for mild cognitive impairment in the elderly?
Conclusion
The study identified three plasma metabolites that can effectively distinguish individuals with mild cognitive impairment from healthy subjects.
Supporting Evidence
- A total of 14 differential metabolites were identified.
- Three metabolites (uric acid, pyruvic acid, and isolithocholic acid) were found to be effective biomarkers for distinguishing MCI patients from healthy controls.
- The study utilized a comprehensive metabolomics approach to analyze plasma samples.
Takeaway
Researchers found specific substances in the blood that can help tell if older people have early signs of memory problems.
Methodology
The study used high-throughput targeted metabolomics to analyze plasma samples from 124 individuals with mild cognitive impairment and 47 healthy controls.
Potential Biases
The imbalance in sample size between groups may introduce bias.
Limitations
The study was cross-sectional, which limits the assessment of the temporal stability of biomarkers, and the sample size of controls was smaller than that of MCI patients.
Participant Demographics
Participants were recruited from rural areas in Qingdao, with a mean age of 73 years, and included 124 individuals with mild cognitive impairment and 47 healthy controls.
Statistical Information
P-Value
p<0.01
Confidence Interval
95% CI: 0.96–1.00
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website